Evidence map›Paper›PMID 18289811›Full record

ArticleInternational journal of pharmaceutics2008

Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles.

Sok Bee Lim, Israel Rubinstein, Hayat Onyüksel

Abstract read
In one paragraph

Article in International journal of pharmaceutics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A novel peptide nanomedicine for treatment of pancreatogenic diabetes.Nanomedicine : nanotechnology, biology, and medicine · 2013
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sok Bee LimDepartment of Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL 60612-7231, USA.
Israel Rubinstein
Hayat Onyüksel

Funding

Phospholipid Nanocarriers Improve Chemotherapy by Targeted Drug DeliveryR01CA121797 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ONYUKSEL, HAYAT · 2007 to 2010
$1.2M
Micellar VIP Nanoparticles for Rheumatoid ArthritisR01AG024026 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RUBINSTEIN, ISRAEL · 2004 to 2007
$1.1M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR015482 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BAUMAN, JERRY L · 2000 to 2000
$909k
NCI NIH HHS R01 CA121797NCRR NIH HHS C06 RR015482NCRR NIH HHS C06 RR15482NIA NIH HHS R01 AG024026
6 · The paper itself

Abstract

The purpose of this study was to determine optimal lipid concentration range for lyophilization of sterically stabilized phospholipid nanomicelles (SSM) and the freeze drying feasibility of self-associated therapeutic peptide-SSM assemblies. SSM at 5-20 mM 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000) (DSPE-PEG(2000)) were analyzed for particle size and viscosity before and after freeze drying which showed no significant changes (p>0.05). However, a steep increase in viscosity was seen for SSM above 15 mM phospholipid implying micelle-micelle interaction. Greater shrinkage of lyophilized cakes was observed below 10 mM phospholipid while they were more fibrous above 15 mM. Therefore, 10-15 mM DSPE-PEG(2000) was chosen as the optimal phospholipid concentration for lyophilized SSM. When vasoactive intestinal peptide (VIP), glucagon-like peptide 1 (GLP-1) or gastric inhibitory peptide (GIP) (each, 67 microM) was added to SSM (10mM), formulations showed no significant change in particle size, peptide fluorescence and peptide alpha-helicity before and after lyophilization. In conclusion, we found that peptide drug-SSM interactions are conserved during lyophilization.

Indexed as

MicellesDrug StabilityFreeze DryingGastric Inhibitory PolypeptideGlucagon-Like Peptide 1NanoparticlesParticle SizePeptidesPhosphatidylethanolaminesPolyethylene GlycolsVasoactive Intestinal PeptideViscosity1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)Gastric Inhibitory PolypeptideGlucagon-Like Peptide 1MicellesPeptidesPhosphatidylethanolaminesPolyethylene GlycolsVasoactive Intestinal Peptide

Identifiers

PMID18289811
PMCPMC2413132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.